General Equity Holdings LP acquired a new position in shares of Oak Street Health, Inc. (NYSE:OSH – Get Rating) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 427,200 shares of the company's stock, valued at approximately $11,483,000. Oak Street Health makes up 8.5% of General Equity Holdings LP's investment portfolio, making the stock its 4th biggest holding. General Equity Holdings LP owned approximately 0.18% of Oak Street Health as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Victory Capital Management Inc. grew its holdings in Oak Street Health by 7.0% in the 1st quarter. Victory Capital Management Inc. now owns 14,994 shares of the company's stock valued at $271,000 after buying an additional 975 shares during the period. Confluence Wealth Services Inc. purchased a new stake in shares of Oak Street Health during the 4th quarter worth about $34,000. Benjamin Edwards Inc. grew its holdings in shares of Oak Street Health by 9,016.7% during the 1st quarter. Benjamin Edwards Inc. now owns 1,094 shares of the company's stock worth $29,000 after purchasing an additional 1,082 shares during the period. Nissay Asset Management Corp Japan ADV grew its holdings in shares of Oak Street Health by 11.8% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 11,943 shares of the company's stock worth $396,000 after purchasing an additional 1,265 shares during the period. Finally, Park Avenue Securities LLC grew its holdings in shares of Oak Street Health by 12.9% during the 1st quarter. Park Avenue Securities LLC now owns 11,145 shares of the company's stock worth $300,000 after purchasing an additional 1,273 shares during the period. Hedge funds and other institutional investors own 91.33% of the company's stock.
Get
Oak Street Health alerts:
Insider Activity at Oak Street Health
In related news, Director Newlight Partners Lp sold 7,000,000 shares of the company's stock in a transaction that occurred on Friday, August 19th. The stock was sold at an average price of $24.72, for a total transaction of $173,040,000.00. Following the sale, the director now directly owns 33,509,640 shares of the company's stock, valued at approximately $828,358,300.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, COO Brian Clem sold 40,000 shares of the company's stock in a transaction on Tuesday, August 2nd. The stock was sold at an average price of $30.00, for a total transaction of $1,200,000.00. Following the completion of the transaction, the chief operating officer now directly owns 596,468 shares in the company, valued at approximately $17,894,040. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Newlight Partners Lp sold 7,000,000 shares of the company's stock in a transaction on Friday, August 19th. The stock was sold at an average price of $24.72, for a total value of $173,040,000.00. Following the transaction, the director now owns 33,509,640 shares of the company's stock, valued at $828,358,300.80. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,248,523 shares of company stock valued at $206,854,025. Corporate insiders own 11.40% of the company's stock.
Analysts Set New Price Targets
A number of analysts have recently issued reports on OSH shares. Morgan Stanley boosted their target price on Oak Street Health from $19.00 to $30.00 and gave the stock an "equal weight" rating in a report on Wednesday, August 31st. Cowen boosted their target price on Oak Street Health to $34.00 in a report on Tuesday, August 9th. Sanford C. Bernstein initiated coverage on Oak Street Health in a research report on Thursday, May 26th. They set an "outperform" rating and a $26.00 price target on the stock. Argus initiated coverage on Oak Street Health in a research report on Tuesday, July 26th. They set a "hold" rating on the stock. Finally, SVB Leerink boosted their price target on Oak Street Health from $23.00 to $32.00 and gave the stock a "market perform" rating in a research report on Thursday, August 4th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $32.75.
Oak Street Health Stock Performance
Shares of OSH stock traded down $0.72 on Monday, hitting $27.61. 21,181 shares of the stock traded hands, compared to its average volume of 2,473,982. The company has a debt-to-equity ratio of 16.10, a current ratio of 1.57 and a quick ratio of 1.57. The company has a market capitalization of $6.66 billion, a PE ratio of -12.88 and a beta of 3.01. Oak Street Health, Inc. has a 1-year low of $13.29 and a 1-year high of $54.14. The company's fifty day moving average is $26.40 and its 200 day moving average is $22.56.
Oak Street Health (NYSE:OSH – Get Rating) last posted its quarterly earnings results on Tuesday, August 2nd. The company reported ($0.66) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by ($0.17). The firm had revenue of $523.70 million for the quarter, compared to analyst estimates of $520.62 million. Oak Street Health had a negative net margin of 27.11% and a negative return on equity of 1,883.59%. On average, equities research analysts predict that Oak Street Health, Inc. will post -2.44 earnings per share for the current fiscal year.
About Oak Street Health
(Get Rating)
Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.
Further Reading
- Get a free copy of the StockNews.com research report on Oak Street Health (OSH)
- 3 Downgraded Must-Have Stocks To Put On Your Watchlist
- This Is What To Expect From The Q3 Earnings Reporting Season
- 3 Biotech Stocks Gaining Momentum
- Can Electronic Arts Buck the Downturn in Videogaming?
- Dollar General is the Big Fish in Little Ponds Across the U.S.
Want to see what other hedge funds are holding OSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oak Street Health, Inc. (NYSE:OSH – Get Rating).
Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.
